Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

2012454 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 13, Issue 2, pp. 135-144

Field-Weighted Citation Impact: 30.28